Aspargo Labs, Inc
11
1
1
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption
Role: lead
Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets
Role: lead
PK and Relative Bioavailability of Novel Liquid Metformin vs Tablets
Role: lead
PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults
Role: lead
Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets
Role: lead
Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets
Role: lead
Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension
Role: lead
Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject
Role: lead
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
Role: lead
Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction
Role: lead
Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants.
Role: lead
All 11 trials loaded